Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 35, 2005 - Issue 10-11
104
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Preclinical pharmacokinetics and metabolism of a potent non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase

, , , , , , , , , , , , , & show all
Pages 1035-1054 | Received 12 Jul 2005, Published online: 22 Sep 2008

References

  • Barr WH, Riegelman S. Intestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption. Journal of Pharmaceutical Sciences 1970; 59: 154–163
  • Beaulieu PL, Tsantrizos YS. Inhibitors of the HCV NS5B polymerase: new hope for the treatment of hepatitis C infections. Current Opinion in Investigational Drugs 2004; 5: 838–850
  • Benet LZ, Galeazzi RL. Noncompartmental determination of the steady-state volume of distribution. Journal of Pharmaceutical Sciences 1979; 68: 1071–1074
  • Chiou WL. We may not measure the correct intestinal wall permeability coefficient of drugs: alternative absorptive clearance concept. Journal of Pharmacokinetics and Biopharmaceutics 1995; 23: 323–331
  • Chiou WL, Buehler PW. Comparison of oral absorption and bioavailablity of drugs between monkey and human. Pharmaceutical Research 2002; 19: 868–874
  • Chiou WL, Jeong HY, Chung SM, Wu TC. Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans. Pharmaceutical Research 2000; 17: 135–140
  • Choi YM, Chung SM, Chiou WL. First-pass accumulation of salicylic acid in gut tissue after absorption in anesthetized rat. Pharmaceutical Research 1995; 12: 1323–1327
  • De Francesco R, Tomei L, Altamura S, Summa V, Migliaccio G. Approaching a new era for hepatitis C virus therapy: inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Research 2003; 58: 1–16
  • Di Bisceglie AM, Hoofnagle JH. Optimal therapy of hepatitis C. Hepatology 2002; 36: S121–S127
  • Di Marco A, Marcucci I, Chaudhary A, Taliani M, Laufer R. Development and validation of a high-throughput radiometric cyp2c9 inhibition assay using tritiated diclofenac. Drug Metabolism and Disposition 2005a; 33: 359–364
  • Di Marco A, Marcucci I, Verdirame M, Perez J, Sanchez M, Pelaez F, Chaudhary A, Laufer R. Development and validation of a high-throughput radiometric CYP3A4/5 inhibition assay using tritiated testosterone. Drug Metabolism and Disposition 2005b; 33: 349–358
  • Di Marco A, Yao D, Laufer R. Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes. European Journal of Biochemistry 2003; 270: 3768–3777
  • Dich J, Grunnet N. Primary cultures of rat hepatocytes. Animal cell culture. Humana, Clifton, NJ 1989; 5: 161–176, Methods in molecular biology
  • Guguen-Guillouzo C, Guillouzo A. Methods for preparation of adult and fetal hepatocytes. Research in isolated and cultured hepatocytes, A Guillouzo, C Guguen-Guillouzo. John Libbey, London 1986; 1–12
  • Guyomard C, Chesne C, Meunier B, Fautrel A, Clerc C, Morel F, Rissel M, Campion JP, Guillouzo A. Primary culture of adult rat hepatocytes after 48-hour preservation of the liver with cold UW solution. Hepatology 1990; 12: 1329–1336
  • Hamelin BA, Turgeon J. Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends in Pharmacological Sciences 1998; 19: 26–37
  • Harper S, Avolio S, Pacini B, Di Filippo M, Altamura S, Tomei L, Paonessa G, Di Marco S, Carfi A, Giuliano C, Padron J, Bonelli F, Migliaccio G, De Francesco R, Laufer R, Rowley M, Narjes F. Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase. Journal of Medicinal Chemistry 2005a; 48: 4547–4557
  • Harper S, Pacini B, Avolio S, Di Filippo M, Migliaccio G, Laufer R, De Francesco R, Rowley M, Narjes F. Development and preliminary optimization of indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase. Journal of Medicinal Chemistry 2005b; 48: 1314–1317
  • Hengstler JG, Utesch D, Steinberg P, Platt KL, Diener B, Ringel M, Swales N, Fischer T, Biefang K, Gerl M, Bottger T, Oesch F. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metabolism Reviews 2000; 32: 81–118
  • Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharmaceutics and Drug Disposition 1995; 16: 351–380
  • Lukas G, Brindle SD, Greengard P. The route of absorption of intraperitoneally administered compounds. Journal of Pharmacology and Experimental Therapeutics 1971; 178: 562–564
  • Ma B, Prueksaritanont T, Lin JH. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metabolism and Disposition 2000; 28: 125–130
  • Prueksaritanont T, DeLuna P, Gorham LM, Ma B, Cohn D, Pang J, Xu X, Leung K, Lin JH. In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318. Roles of efflux and metabolism. Drug Metabolism and Disposition 1998; 26: 520–527
  • Stella VJ, Rajewski RA. Cyclodextrins: their future in drug formulation and delivery. Pharmaceutical Research 1997; 14: 556–567
  • Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Seminars in Liver Disease 2000; 20: 1–16
  • Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I. Evaluation of rat intestinal absorption data and correlation with human intestinal absorption. European Journal of Medicinal Chemistry 2003; 38: 233–243

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.